Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Radiation therapy for intrahepatic malignancies
Expert Review of Anticancer Therapy, 10/26/09
Quick AM et al. – Historically, radiation was not used in the management of hepatocellular carcinoma and liver metastasis because of the low tolerance of the liver to radiation. This review will discuss the different techniques of radiation that can now be used to treat intrahepatic malignancies and the important clinical studies in the medical literature.
Related Articles
Hormone Therapy Can Help Some with Prostate Cancer
MedLinePlus, 11/04/09
Relevance Score: 69%
Systematic Review: Charged-Particle Radiation Therapy for Cancer
Annals of Internal Medicine, 10/20/09
Relevance Score: 69%
Is Radiation Therapy for Keloids Acceptable? The Risk of Radiation-Induced Carcinogenesis
Plastic and Reconstructive Surgery, 10/12/09
Relevance Score: 69%
Radiation therapy for early breast cancer
Clinical and Translational Oncology, 10/07/09
Relevance Score: 69%
Shorter Radiation Course Stops Cancer Growth In High-risk Prostate Cancer Patients
ScienceDaily, 11/12/09
Relevance Score: 68%
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoblastoma metastatic to the right atrium responding to chemotherapy alone
Pediatric Hematology and Oncology, 11/25/09
Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancer
Journal of Cancer Research & Clinical Oncology, 11/23/09
L1 Cell Adhesion Molecule Is a Novel Independent Poor Prognostic Factor of Extrahepatic Cholangiocarcinoma
Clinical Cancer Research, 11/20/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
Oncogene, 11/25/09
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
Investigational New Drugs, 11/25/09
Adding more content to screening: reactivation of FOXO as a therapeutic strategy
Clinical and Translational Oncology, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


